- 関
- delavirdine
WordNet
- a non-nucleoside reverse transcriptase inhibitor (trade name Rescriptor) used to treat AIDS and HIV (同)Rescriptor
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Gateways to clinical trials.
- Bayés M1, Rabasseda X, Prous JR.
- Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2002 Dec;24(10):703-29.
- Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.c
- PMID 12616965
- Gateways to clinical trials.
- Bayés M1, Rabasseda X, Prous JR.
- Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2002 Nov;24(9):615-43.
- Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.c
- PMID 12616707
Related Links
- It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1. It is presented as the mesylate. The recommended dosage is 400 mg, three times a day. Although delavirdine was ...
★リンクテーブル★
[★]
- 英
- delavirdine mesilate
- 関
- デラビルジン
[★]
メシル酸、(化合物)シル酸塩、メタンスルホン酸塩
- 関
- mesylate、methanesulfonate